Form 4: Gilead Sciences SVP Sandra Patterson Reports Stock Transactions

Sandra Patterson, SVP, Controllership at Gilead Sciences, reports the acquisition and disposal of common stock and restricted stock units.

Summary

• On September 10, 2024, Sandra Patterson, SVP, Controllership at Gilead Sciences, engaged in transactions involving the company's stock.
• Patterson acquired 901 shares of common stock through the vesting of restricted stock units.
• She also disposed of 292 shares of common stock to cover tax obligations at a price of $81.44 per share.
• Following these transactions, Patterson directly owns 36,585 shares of Gilead Sciences common stock and 13,183 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an executive, with no inherent positive or negative sentiment.

Positives

• The vesting of restricted stock units indicates a continued alignment of the executive's interests with those of the shareholders.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock. It is standard practice for executives to receive and vest stock options and restricted stock units as part of their compensation packages.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they represent routine executive compensation activities.

Key Dates